Morishita Jintan Co., Ltd. (4524.T)

JPY 2079.0

(-0.29%)

Long Term Debt Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual long term debt in 2023 was 106 Million JPY , down -56.2% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was 84 Million JPY , down -20.75% from previous quarter.
  • Morishita Jintan Co., Ltd. reported annual long term debt of 242 Million JPY in 2022, down -48.4% from previous year.
  • Morishita Jintan Co., Ltd. reported annual long term debt of 469 Million JPY in 2021, down -37.38% from previous year.
  • Morishita Jintan Co., Ltd. reported quarterly long term debt of 163 Million JPY for 2023 Q2, down -19.31% from previous quarter.
  • Morishita Jintan Co., Ltd. reported quarterly long term debt of 106 Million JPY for 2023 Q4, down -27.89% from previous quarter.

Annual Long Term Debt Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Long Term Debt of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 106 Million JPY -56.2%
2022 242 Million JPY -48.4%
2021 469 Million JPY -37.38%
2020 749 Million JPY -8.77%
2019 821 Million JPY 0.0%

Peer Long Term Debt Comparison of Morishita Jintan Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 91.389%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.998%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.921%
Shionogi & Co., Ltd. 8.75 Billion JPY 98.789%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 90.799%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.921%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -39.474%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 98.49%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 99.206%
Tsumura & Co. 54.37 Billion JPY 99.805%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -381.818%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.944%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 99.111%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 98.666%
KYORIN Holdings, Inc. 435 Million JPY 75.632%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 96.133%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 97.73%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -292.593%
Modalis Therapeutics Corporation 412.5 Million JPY 74.303%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 97.647%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.841%
Cyfuse Biomedical K.K. 345 Million JPY 69.275%
Toho Holdings Co., Ltd. 28.16 Billion JPY 99.624%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 93.339%